Who owns Northwest Biotherapeutics In?
- Ticker: NWBO
- CUSIP Number: 66737P600
Tip: Access positions for across all investors
Analyze quarterly positions in Northwest Biotherapeutics In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Northwest Biotherapeutics In stock
Who bought or sold Northwest Biotherapeutics In this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Moloney Securities Asset Management | 380k | $197k | 6% | Mar 2024 |
|
| Opus Capital Group | 60k | $31k | 0% | Mar 2024 |
|
| Williams Jones Wealth Management | 40k | $21k | -9% | Mar 2024 |
|
| Ethos Financial Group | 24k | $12k | 100% | Mar 2024 |
|
| Lee, Danner & Bass | 20k | $14k | 0% | Dec 2023 |
|
| MAI Wealth Advisors | 20k | $10k | 0% | Mar 2024 |
|
| AlphaMark Advisors | 14k | $7.0k | 100% | Mar 2024 |
|
| Advisors Management Group | 10k | $5.0k | 0% | Mar 2024 |
|
| Bartlett & Co. | 4.3k | $3.0k | 0% | Dec 2023 |
|
| Coston, McIsaac & Partners | 1.0k | $0 | 0% | Mar 2024 |
|
Who sold out of Northwest Biotherapeutics In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bartlett & Co. Wealth Management | Dec 2023 | 4.3k | $3.1k |